These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3340199)

  • 1. Row over vaccine trial.
    Palca J
    Nature; 1988 Feb; 331(6156):470. PubMed ID: 3340199
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.
    Pastoret PP; Brochier B; Boulanger D
    Dev Biol Stand; 1995; 84():183-93. PubMed ID: 7796953
    [No Abstract]   [Full Text] [Related]  

  • 4. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunization of calves with a rabies vaccine from suckling mouse brain].
    Díaz AM; Lombardo RA
    Rev Argent Microbiol; 1981; 13(2):45-8. PubMed ID: 6765751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rabies vaccine in Czechoslovakia. I. Hempt's vaccine and its modification].
    Slonim D; Stastný F; Brázdová AR
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):257-65. PubMed ID: 6215991
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential effect of prior raccoonpox virus infection in raccoons on vaccinia-based rabies immunization.
    Root JJ; McLean RG; Slate D; MacCarthy KA; Osorio JE
    BMC Immunol; 2008 Oct; 9():57. PubMed ID: 18834520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rabies in supposedly vaccinated children, cases of long incubation (apropos of 2 cases)].
    Fellat-Hamdouch R; Mouhadden F; Jorio M; Malki-Tazi A
    Maghrib Tibbi; 1981 Dec; 3(4):793-803. PubMed ID: 7348286
    [No Abstract]   [Full Text] [Related]  

  • 10. Rabies postexposure prophylaxis with human diploid cell rabies vaccine: lower neutralizing antibody titers with Wyeth vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):90-2. PubMed ID: 3918250
    [No Abstract]   [Full Text] [Related]  

  • 11. New vaccine and initiative mean end of rabies in sight for Europe?
    Newmark P
    Nature; 1988 Dec; 336(6198):416. PubMed ID: 3194027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rabies vaccine in Czechoslovakia. II. Lyophilized rabies vaccine from brain tissue inactivated by UV irradiation].
    Slonim D; Stastný F; Brázdová R
    Cesk Epidemiol Mikrobiol Imunol; 1983 Jan; 32(1):17-26. PubMed ID: 6218902
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody response to a single intradermal booster dose of rabies human diploid cell vaccine.
    Dreesen DW; Kemp DT; Brown J; Brown WJ
    J Am Vet Med Assoc; 1983 Dec; 183(12):1468-70. PubMed ID: 6654729
    [No Abstract]   [Full Text] [Related]  

  • 14. [Construction and characterization of non-replicating recombinant vaccinia virus expressing rabies glycoprotein].
    Li P; Hu Q; Sun Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):170-4. PubMed ID: 12569788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatives for potency testing of veterinary vaccines: rabies vaccine as a model.
    Bruckner L; Kihm U
    Dev Biol Stand; 1986; 64():93-7. PubMed ID: 3792660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of monoclonal antibodies to confirm vaccine-induced rabies in ten dogs, two cats, and one fox.
    Whetstone CA; Bunn TO; Emmons RW; Wiktor TJ
    J Am Vet Med Assoc; 1984 Aug; 185(3):285-8. PubMed ID: 6540768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine.
    Pengsaa K; Limkittikul K; Sabchareon A; Ariyasriwatana C; Chanthavanich P; Attanath P; Malerczyk C
    Pediatr Infect Dis J; 2009 Apr; 28(4):335-7. PubMed ID: 19333080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
    Sureau P; Rollin P; Lafon M
    Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of BHK-rabies vaccine in human volunteers.
    Lalosević D; Stankov S; Lazarević-Ivanc L; Lalosević V; Knezević I
    Med Pregl; 1998; 51 Suppl 1():17-9. PubMed ID: 9769650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.